98%
921
2 minutes
20
The chb operon of Escherichia coli is involved in the utilization of the β-glucosides chitobiose and cellobiose. The function of chbG (ydjC), the sixth open reading frame of the operon that codes for an evolutionarily conserved protein is unknown. We show that chbG encodes a monodeacetylase that is essential for growth on the acetylated chitooligosaccharides chitobiose and chitotriose but is dispensable for growth on cellobiose and chitosan dimer, the deacetylated form of chitobiose. The predicted active site of the enzyme was validated by demonstrating loss of function upon substitution of its putative metal-binding residues that are conserved across the YdjC family of proteins. We show that activation of the chb promoter by the regulatory protein ChbR is dependent on ChbG, suggesting that deacetylation of chitobiose-6-P and chitotriose-6-P is necessary for their recognition by ChbR as inducers. Strains carrying mutations in chbR conferring the ability to grow on both cellobiose and chitobiose are independent of chbG function for induction, suggesting that gain of function mutations in ChbR allow it to recognize the acetylated form of the oligosaccharides. ChbR-independent expression of the permease and phospho-β-glucosidase from a heterologous promoter did not support growth on both chitobiose and chitotriose in the absence of chbG, suggesting an additional role of chbG in the hydrolysis of chitooligosaccharides. The homologs of chbG in metazoans have been implicated in development and inflammatory diseases of the intestine, indicating that understanding the function of E. coli chbG has a broader significance.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430350 | PMC |
http://dx.doi.org/10.1128/JB.00533-12 | DOI Listing |
Cochrane Database Syst Rev
September 2025
Editorial Team, Cochrane Hepato-Biliary Group, Wheelwright, Argentina.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of oral bile acid-based therapies versus no intervention or placebo, or versus a different bile acid-based therapy, at any dose or regimen, in adults diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD).
View Article and Find Full Text PDFCochrane Database Syst Rev
August 2025
Department of Therapy, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Objectives: This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows: To determine the diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index (APRI) for staging and screening fibrosis in adults with chronic hepatitis C infection when compared with liver biopsy as the reference standard. To achieve this, we will compare at least significant fibrosis (stages F2-F4) to no significant fibrosis (stages F0-F1) as this group of people is prioritised for treatment; at least advanced fibrosis (stages F3-F4) compared to no advanced fibrosis (stages F0-F2) as this group of people is at high risk for developing complications, i.
View Article and Find Full Text PDFJ Community Hosp Intern Med Perspect
May 2025
Chorea, characterized by sudden, involuntary movements of the face and limbs, arises from various causes, including neurodegenerative diseases, metabolic disorders, and structural brain changes, notably in the basal ganglia. Acute lesions in the basal ganglia due to ischemia or vascular pathology can also precipitate chorea. Hyperglycemia-induced basal ganglia changes, termed chorea hyperglycemia basal ganglia, predominantly affect elderly females with type 2 diabetes.
View Article and Find Full Text PDFClin Med Insights Case Rep
May 2025
Squad Medicine and Research (SMR), Amadalavalasa, Andhra Pradesh, India.
Chorea Hyperglycemia Basal Ganglia Syndrome (CHBG) is an uncommon neurological complication arising in diabetic patients with severe, non-ketotic hyperglycemia. This case report describes a 50-year-old woman presenting with new-onset, choreiform movements in her extremities. Initial workup revealed uncontrolled diabetes (plasma glucose 410 mg/dl, HbA1c 11.
View Article and Find Full Text PDFRev Esp Geriatr Gerontol
March 2025
Servicio de Neurología, Hospital Universitari de Vic, Vic, Barcelona, España.